A detailed history of Fmr LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Fmr LLC holds 5,625,856 shares of RVMD stock, worth $310 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,625,856
Previous 4,166,765 35.02%
Holding current value
$310 Million
Previous $134 Million 62.58%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$30.14 - $40.68 $44 Million - $59.4 Million
1,459,091 Added 35.02%
5,625,856 $218 Million
Q1 2024

May 13, 2024

BUY
$26.56 - $33.55 $69,454 - $87,733
2,615 Added 0.06%
4,166,765 $134 Million
Q4 2023

Feb 13, 2024

BUY
$18.35 - $34.12 $63.6 Million - $118 Million
3,465,332 Added 495.88%
4,164,150 $119 Million
Q3 2023

Nov 13, 2023

BUY
$25.17 - $35.05 $2.92 Million - $4.07 Million
116,106 Added 19.93%
698,818 $19.3 Million
Q2 2023

Aug 11, 2023

SELL
$20.28 - $27.0 $323,648 - $430,893
-15,959 Reduced 2.67%
582,712 $15.6 Million
Q1 2023

May 11, 2023

BUY
$20.76 - $30.09 $3.51 Million - $5.08 Million
168,904 Added 39.3%
598,671 $13 Million
Q4 2022

Feb 13, 2023

SELL
$17.68 - $25.53 $52,739 - $76,155
-2,983 Reduced 0.69%
429,767 $10.2 Million
Q3 2022

Nov 10, 2022

BUY
$17.46 - $26.0 $6.41 Million - $9.55 Million
367,197 Added 560.15%
432,750 $8.53 Million
Q2 2022

Aug 12, 2022

SELL
$14.54 - $27.17 $40.7 Million - $76.1 Million
-2,801,467 Reduced 97.71%
65,553 $1.28 Million
Q1 2022

May 13, 2022

SELL
$17.31 - $26.4 $56 Million - $85.4 Million
-3,234,704 Reduced 53.01%
2,867,020 $73.1 Million
Q4 2021

Feb 14, 2022

SELL
$24.35 - $33.7 $41.3 Million - $57.2 Million
-1,696,160 Reduced 21.75%
6,101,724 $154 Million
Q3 2021

Nov 15, 2021

SELL
$23.95 - $33.41 $41.6 Million - $58 Million
-1,736,375 Reduced 18.21%
7,797,884 $215 Million
Q2 2021

Aug 13, 2021

BUY
$29.0 - $47.44 $276 Million - $452 Million
9,534,259 New
9,534,259 $303 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.83B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.